Vistagen Therapeutics, Inc. Common Stock

$0.5803
-0.0163 (-2.73%)

Market Capitalization:

$22.99M

Vistagen Therapeutics Price Chart

Vistagen Therapeutics Price Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM0.63800.62600.61400.60200.59010.57810.57

Vistagen Therapeutics Volume Chart

Vistagen Therapeutics Volume Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM36.00K30.86K25.72K20.57K15.43K10.29K5.14K

Vistagen Therapeutics Market Segments

Premarket

+0.0000(+0.00%)
Open$0.5803
Close$0.5803
Low$0.5803
Low Change0.0000 (0.00%)
High$0.5803
High Change+0.0000 (+0.00%)
Range$0.0000
Volume108
Dollar Volume$62.67

After Hours Yesterday

-0.0244(-4.00%)
Open$0.6094
Close$0.5850
Low$0.5660
Low Change-0.0434 (-7.12%)
High$0.6890
High Change+0.0796 (+13.06%)
Range$0.1230
Volume138.79K
Dollar Volume$81.19K

Regular Trading Hours Yesterday

+0.0166(+2.86%)
Open$0.5800
Close$0.5966
Low$0.5661
Low Change-0.0139 (-2.40%)
High$0.6100
High Change+0.0300 (+5.17%)
Range$0.0439
Volume347.44K
Dollar Volume$207.28K

Premarket Yesterday

+0.0112(+1.98%)
Open$0.5661
Close$0.5773
Low$0.5660
Low Change-0.0001 (-0.02%)
High$0.5773
High Change+0.0112 (+1.98%)
Range$0.0113
Volume3.059K
Dollar Volume$1.77K

Vistagen Therapeutics Moving Averages

5 Day Moving Average (SMA5)$0.5872
10 Day Moving Average (SMA10)$0.5988
20 Day Moving Average (SMA20)$0.5838
50 Day Moving Average (SMA50)$0.5910
100 Day Moving Average (SMA100)$0.9814
200 Day Moving Average (SMA200)$2.2481

Vistagen Therapeutics Statistics

Average Volume (30 Days)771.08K
P/E Ratio (Current)-.34
EPS (Current)-$1.69
Dividend Yield0.00%
Free Cash Flow-$60.54M
Cash Ratio3.50
Current Ratio4.67
Quick Ratio4.67
Debt to Equity0.01
Enterprise Value-$24.41M
EV to EBITDA0.35
EV to Sales-30.90
Price to Book0.44
Price to Cash Flow
Price to Free Cash Flow
Price to Sales28.59
Return on Assets-1.03%
Return on Equity-1.32%

Vistagen Therapeutics Stock Splits

There has been 1 stock split for Vistagen Therapeutics (VTGN). The reverse stock split occured on June 7, 2023 and reduced the outstanding shares at a ratio of 30:1.

DateTypeRatio
Jun 7, 2023Reverse30:1

Vistagen Therapeutics Dividends

There have been no dividends for Vistagen Therapeutics (VTGN).